October 08, 2026 01:59 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50% | ‘Completely false’: Virat Kohli reacts to ₹5 crore claim over Premanand Maharaj visit | We’re watching it very closely: US urges Russia to share more information on plague situation | This isn’t about schools: Trump blames ‘mass migration’ and Islam for violent protests across France | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row

Donald Trump announces new COVID-19 vaccine efforts

| @indiablooms | May 16, 2020, at 01:35 pm

Washington/Xinhua/UNI: US President Donald Trump announced on Friday two men will lead his administration's new effort for COVID-19 vaccine development.

Former pharmaceutical executive Moncef Slaoui and Army General Gustave Perna, the commander of United States Army Materiel Command, will lead "Operation Warp Speed," the new project to accelerate the vaccine development process for COVID-19.

The new project is a "historic partnership" of federal agencies, Trump told a noon briefing in the White House Rose Garden.

He said experts throughout the government have been evaluating 100 vaccine candidates. Among them, 14 vaccine candidates are showing promise.

Trump said he is hopeful a COVID-19 vaccine can be developed by the end of the year.

"Typically pharmaceutical companies wait to manufacture a vaccine until it has received all the regulatory approvals necessary, and this can delay the vaccine's availability to the public as much as a year, even more than that," Trump said.

The federal government will invest in manufacturing all of the top vaccine candidates before they are approved, according to Trump.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine, and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020," said Slaoui, former chair of the vaccines division at pharmaceutical GlaxoSmithKline, a British multinational pharmaceutical company headquartered in London.

He said that in addition to a vaccine, the new project will also focus on the development of medicines for those COVID-19 infected, as well as improving and "optimizing" diagnostic tests. 

Image: Pixabay

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.